miklos pless
机构: Kantonsspital Winterthur
每年引用次数
引用次数
引用: 15,662
H-指数: 48
I10-指数 : 106
出版物: 371
C-Reactive Protein and Fever in Neutropenic Patients
Caroline Arber , Jakob R Passweg , Ursula Fluckiger , Miklos Pless
Scandinavian Journal of Infectious Diseases 32 ( 5) 515 -520
21
2000
Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions
Andreas H Diacon , Christoph Wyser , Christoph T Bolliger , Michael Tamm
American Journal of Respiratory and Critical Care Medicine 162 ( 4) 1445 -1449
111
2000
Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC): Primary analysis of the single arm phase II trial SAKK 06/17.
Richard Cathomas , Sacha Rothschild , Stefanie Hayoz , Martin Spahn
Journal of Clinical Oncology 40 ( 16_suppl) 4515 -4515
13
2022
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging
Carol Oliveira , Florian Amstutz , Diem Vuong , Marta Bogowicz
EJNMMI research 11 ( 1) 79 -79
15
2021
SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III (N2) non-small cell lung cancer (NSCLC)—A multicenter phase II trial.
Laetitia A Mauti , Tobias Finazzi , Lisa Holer , Adrienne Bettini
Journal of Clinical Oncology 41 ( 16_suppl) 8547 -8547
4
2023
Peptide receptor radionuclide therapy for a phosphaturic mesenchymal tumor
Simon Häfliger , Ann-Katrin Seidel , Eric Schoch , Jan Reichmann
Case reports in oncology 13 ( 3) 1373 -1380
5
2021
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Alexandros Papachristofilou , Jens Bedke , Stefanie Hayoz , Ulrich Schratzenstaller
The Lancet Oncology 23 ( 11) 1441 -1450
26
2022
Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial
Alexandra Uster , Maya Ruehlin , Stefanie Mey , David Gisi
Clinical Nutrition S0261561418325445
112
2018
Importance de l’histologie pour le traitement du carcinome bronchique non à petites cellules à un stade avancé
Sacha Rothschild , Daniel C Betticher , Adrian Ochsenbein , Rolf Stahel
Forum Med Suisse 10 ( 22) 384 -388
2
2010
Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer
Jürgen Hetzel , Laetitia A Mauti , Jonas Winkler , Sabine Cardoso Almeida
Journal of Clinical Medicine 12 ( 6) 2355 -2355
1
2023
Outcome and Prognostic factors of COVID-19 infection in Swiss cancer patients: final results of SAKK 80/20 (Casa)
Markus Joerger , Yannis Metaxas , Khalil Zaman , Olivier Michielin
Cancers 14 ( 9) 2191 -2191
4
2022
Extended resection for potentially operable patients with stage III non–small cell lung cancer after induction treatment
Katarzyna Furrer , Walter Weder , Eric Innocents Eboulet , Daniel Betticher
The Journal of thoracic and cardiovascular surgery 164 ( 6) 1587 -1602. e5
11
2022
ORIGINAL REPORTS-Lung Cancer-Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung
Daniel C Betticher , Shu-Fang Hvu Schmitz , Martin Totsch , Eva Hansen
Journal of Clinical Oncology 21 ( 9) 1752 -1759
2003
A phase II clinical trial of tumor-treating field (TTF) therapy concomitant to pemetrexed for advanced non-small cell lung cancer (NSCLC).
Miklos Pless , Daniel C Betticher , Cornelia M Droege , Marc Oliver Salzberg
Journal of Clinical Oncology 30 e18012 -e18012
The murine DUB-1 gene is specifically induced by the βc subunit of the interleukin-3 receptor
Yuan Zhu , Miklos Pless , Roger Inhorn , Bernard Mathey-Prevot
Molecular and cellular biology 16 ( 9) 4808 -4817
76
1996
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin’s lymphoma: results from a phase II multicenter study
Miklos Pless , Karim Belhadj , Hans D Menssen , Wolfgang Kern
Clinical cancer research 10 ( 4) 1299 -1305
60
2004
SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.
Sacha Rothschild , Alfred Zippelius , Spasenija Savic , Michel Gonzalez
Journal of Clinical Oncology 36 ( 15_suppl) TPS8584 -TPS8584
12
2018
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
Nasser Hanna , Frances A Shepherd , Frank V Fossella , Jose R Pereira
Journal of Clinical Oncology 41 ( 15) 2682 -2690
5
2023
A rare differential diagnosis of an adrenal mass: a case report
Ann-Katrin Seidel , Miklos Pless , Christian Michel , Christopher Soll
Case Reports in Oncology 10 ( 3) 981 -986
2
2018
Eine ungewöhnliche Nebennieren-Raumforderung: Ein FallberichtAnn-Katrin Seidela Miklos Plessa Christian Michelb Christopher Sollc Caroline Hochulid Jacques Gublere
Ann-Katrin Seidel , Miklos Pless , Christian Michel , Christopher Soll
Kompass Onkologie 5 ( 1) 59 -62
1
2018